Literature DB >> 2440502

An approximately 300 bp deletion involving part of the 5' beta-globin gene region is observed in members of a Turkish family with beta-thalassemia.

J C Diaz-Chico, K G Yang, A Kutlar, A L Reese, M Aksoy, T H Huisman.   

Abstract

Detailed gene mapping analyses of genomic DNA from two Turkish subjects with a beta-thalassemia trait demonstrated an approximately 300 bp deletion, which is located between the Rsa I restriction site 128 bp 5' to the Cap site and the Acc I restriction site 284 bp 3' to the same Cap site; it includes the 5' beta promoter region, the first exon, and (part of) the IVS-I. Heterozygotes for this and two other beta-thalassemia types, which are also caused by deletions involving 5' beta promoter sequences, appear to have higher hemoglobin (Hb) A2 levels, perhaps because the loss of this promoter results in an increased transcription of the delta globin gene, as delta and beta promoters may be influenced by the same enhancing sequences 3' to the beta globin gene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440502

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Filipino beta zero thalassaemia: a high Hb A2 beta zero thalassaemia resulting from a large deletion of the 5' beta globin gene region.

Authors:  P I Motum; A Kearney; T J Hamilton; R J Trent
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

2.  A beta-thalassemia mutant caused by a 300-bp deletion in the human beta-globin gene.

Authors:  C Aulehla-Scholz; R Spiegelberg; J Horst
Journal:  Hum Genet       Date:  1989-02       Impact factor: 4.132

3.  The in vivo expression of the globin genes of the beta cistron in gamma-, delta-, and delta beta-thalassemia heterozygotes.

Authors:  A J Dimovski; A D Adekile; T H Huisman
Journal:  Experientia       Date:  1994-02-15

4.  The First Report of a 290-bp Deletion in β-Globin Gene in the South of Iran.

Authors:  Mohammad Hamid; Ladan Dawoody Nejad; Gholamreza Shariati; Hamid Galehdari; Alihossein Saberi; Marziye Mohammadi-Anaei
Journal:  Iran Biomed J       Date:  2016-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.